Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice
Open accessAbstract
Collagen VI-related myopathies are disorders of connective tissue presenting with an overlap phenotype combining clinical involvement from the muscle and from the connective tissue. Not all patients displaying related overlap phenotypes between muscle and connective tissue have mutations in collagen VI. Here, we report a homozygous recessive loss of function mutation and a de novo dominant mutation in collagen XII (COL12A1) as underlying a novel overlap syndrome involving muscle and connective tissue. Two siblings homozygous for a loss of function mutation showed widespread joint hyperlaxity combined with weakness precluding independent ambulation, while the patient with the de novo missense mutation was more mildly affected, showing improvement including the acquisition of walking. A mouse model with inactivation of the Col12a1 gene showed decreased grip strength, a delay in fiber-type transition and a deficiency in passive force generation while the muscle seems more resistant to eccentric contraction induced force drop, indicating a role for a matrix-based passive force-transducing elastic element in the generation of the weakness. This new muscle connective tissue overlap syndrome expands on the emerging importance of the muscle extracellular matrix in the pathogenesis of muscle disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Five families with mEDS have been reported: four with autosomal dominant and one with autosomal recessive inheritance.
“So far, five families have been reported: four with an autosomal dominant condition and one with an autosomal recessive condition.”
From The 2017 international classification of the Ehlers–Danlos syndromes (2017) · cites this paper as Zou et al., 2014
The Discussion reports three patients in two families and says COL12A1 disease can arise through both recessive and dominant mechanisms. It does not support the claimed total of five families or the breakdown of four dominant and one recessive family. (LLM, conf=0.90)
Experimental — accuracy not yet measuredThrough these studies they identified eight patients in four families that presented with autosomal recessive (two patients, one family) and dominant (six patients, three families) forms of EDS/myopathy.
“Through these studies they identified eight patients in four families that presented with autosomal recessive (two patients, one family) and dominant (six patients, three families) forms of EDS/myopathy.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
Clinical findings (p. 2340) describes two affected brothers in family A, and Haplotype and mutation analysis identifies their homozygous COL12A1 mutation. Clinical findings describes one affected boy in family B, whose mutation the Discussion calls dominant. The retrieved passages do not support the claimed total of eight patients in four families, including six dominant cases in three families. (LLM, conf=0.84)
Experimental — accuracy not yet measuredTo date, nine patients from five families with myopathic EDS have been reported.
“To date, nine patients from five families with myopathic EDS have been reported [Hicks et al., 2014;Zou et al., 2014;Punetha et al., 2016]”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
The Clinical findings section reports two affected brothers in family A and one affected boy in family B. This supports three patients from two families as part of the cited reports, but this paper does not establish the sentence’s total of nine patients from five families. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe siblings reported by Zou et al. [2014] (homozygous mutation) had the most severe phenotype with profound muscle hypotonia at birth, poor feeding and swallowing, and night-time hypoventilation, with need for tube feeding and non-invasive night-time ventilation.
“The siblings reported by Zou et al. [2014] (homozygous mutation) had the most severe phenotype with profound muscle hypotonia at birth, poor feeding and swallowing, and night-time hypoventilation, with need for tube feeding and non-invasive night-time ventilation.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
The Clinical findings (p. 2340) describe both brothers as severely weak at birth, and the Discussion identifies their homozygous mutation and severe phenotype. However, poor feeding and swallowing, tube feeding, night-time hypoventilation, and non-invasive ventilation are documented specifically for patient A1; the copy does not establish that his brother A2 also had them. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe affected siblings from the family with autosomal recessive mEDS have a more severe form than patients with autosomal dominant inheritance.
“The affected siblings from the family with the autosomal recessive condition have a more severe form of the condition than patients with autosomal dominant inheritance [Zou et al., 2014].”
From The 2017 international classification of the Ehlers–Danlos syndromes (2017) · cites this paper as Zou et al., 2014
Zou et al. [2014] and Hicks et al. [2014] investigated groups of patients that had some symptoms of these myopathies but presented with a distinctive phenotype and did not have mutations affecting type VI collagen.
“Zou et al. [2014] andHicks et al. [2014] investigated groups of patients that had some symptoms of these myopathies but presented with a distinctive phenotype and did not have mutations affecting type VI collagen.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
Collagen XII is found along the surfaces of the fibers of collagen type I in tissues that express that collagen, and it is presumed to act as a bridge between the collagen I fibers and other extracellular components including decorin, fibromodulin, and TNX.
“It is found along the surfaces of the fibers of collagen type I in tissues that express that collagen, and it is presumed to act as a bridge between the collagen I fibers and other extracellular components including decorin, fibromodulin, and TNX [Zou et al., 2014].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
There appears to be a mild phenotype (dominant) in carriers and a severe phenotype (recessive) in individuals that are homozygous for the autosomal recessive myopathic EDS mutation.
“Reportedly carrier parents walked late (almost at 2 years of age); therefore there appears to be a mild phenotype (dominant) in the carriers and a severe phenotype (recessive) in the individuals that are homozygous [Zou et al., 2014].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
The siblings reported by Zou et al. [2014] had a severe delay in motor development, and they eventually were able to reach a sitting position, but were never able to stand or walk.
“They had a severe delay in motor development, and they eventually were able to reach a sitting position, but were never able to stand or walk [Zou et al., 2014].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
Their age at publication ranged from birth to 48 years.
“Their age at publication ranged from birth to 48 years (Table S1) [Hicks et al., 2014;Zou et al., 2014;Punetha et al., 2016].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zou et al., 2014
The Clinical findings (around p. 2340) describe symptoms at birth and events at ages 2, 3, and 9, but do not give the patients’ ages at publication. Searches for publication ages and 48 years found no passage establishing the stated range in this paper; the sentence also cites two other sources, which were not assessed. (LLM, conf=0.73)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Hicks, D., Farsani, G.T. and Laval, S. Mutations in the Collagen XII gene define a new form of extracellular matrix related myopathy. Hum. Mol. Genet. doi:10.1093/hmg/ddt637. · DOI · Paper page
- Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA, 90, 3710-3714.
- Tillet, E., Wiedemann, H., Golbik, R., Pan, T.C., Zhang, R.Z., Mann, K., Chu, M.L. and Timpl, R. (1994) Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI [published erratum appears in Eur J Biochem 1994 Jun 15;222(3):1064]. Eur. J. Biochem., 221, 177-185.
- Moorwood, C., Liu, M., Tian, Z. and Barton, E.R. (2013) Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies. J. Vis. Exp., 71, e50036. 2352 Human Molecular Genetics, 2014, Vol. 23, No. 9
Cited by
Sorted by citations
The 2017 international classification of the Ehlers–Danlos syndromes
Malfait, F., Francomano, C., Byers, P., Belmont, J., Berglund, B., Black, J., Bloom, L., Bowen, J. M., Brady, A. F., Burrows, N. P., et al. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31552 · Cited by 1,936 · see citing works
Self-citationThe Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 249 · see citing works
Self-citationScott, R. W., Arostegui, M., Schweitzer, R., Rossi, F. M. V., & Underhill, T. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.11.004 · Cited by 214 · see citing works
Tenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132 · see citing works
Ghibellini, G., Brancati, F., & Castori, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31424 · Cited by 53 · see citing works
Genetics of the Ehlers–Danlos syndrome: More than collagen disorders
Van Damme, T., Syx, D., Coucke, P., Symoens, S., De Paepe, A., & Malfait, F. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1022528 · Cited by 4 · see citing works
- Authors
- Zou, Y., Zwolanek, D., Izu, Y., Gandhy, S., Schreiber, G., Brockmann, K., Devoto, M., Tian, Z., Hu, Y., Veit, G., Meier, M., Stetefeld, J., Hicks, D., Straub, V., Voermans, N. C., Birk, D. E., Barton, E. R., Koch, M., & Bönnemann, C. G.
- Affiliations
- National Institutes of Health (US)
- University of Cologne (DE)
- University of South Florida (US)
- Universitätsmedizin Göttingen (DE)
- Children's Hospital of Philadelphia (US)
- University of Pennsylvania (US)
- University of Manitoba (CA)
- Newcastle University (GB)
- Radboud University Medical Center (NL)
- Corresponding author
- Koch, Manuel
- Bönnemann, Carsten G.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-11
- Volume
- 23
- Issue
- 9
- Pages
- 2339-2352
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC3976332
- OpenAlex
- W2121643812
- Cited by
- 143
- References
- 1
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 12 · 2023: 13 · 2022: 8 · 2021: 16 · 2020: 22 · 2019: 12 · 2018: 8 · 2017: 4 · 2016: 9 · 2015: 11 · 2014: 4 · 2013: 1
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Human Molecular Genetics (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Medical Research Council (MR/K000608/1)
- National Cancer Institute (P01CA078890)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR052646, R01AR044745, NIH AR044745)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- COL12A1, collagen XII, elastic fibers, Ehlers-Danlos syndrome, myopathy, overlap syndrome, connective tissue diseases, joint hyperlaxity, muscle weakness, mouse model, extracellular matrix, muscle fiber type transition, eccentric contraction
- MeSH terms
- Animals, Child, Preschool, Disease Models, Animal, Humans, Infant, Male, Muscular Diseases, Mutation, Muscle, Skeletal, Collagen Type XII, Collagen Type VI, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review